Americana Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Americana Partners's NVO Position: Q2 2026 in Review
Americana Partners increased its Novo Nordisk (NVO) stake by 14% in Q2 2026, buying an estimated $495K and bringing the position to 96,757 shares worth $4.64M. The position accounts for 0.1% of the portfolio, ranked #147.
Americana Partners first reported a position in NVO in Q4 2019 and has held it in 19 quarters since. The position peaked at $7.05M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Americana Partners held 96,757 shares of Novo Nordisk worth $4.64M as of Q2 2026.
- Americana Partners bought 11,520 Novo Nordisk shares in Q2 2026, an estimated $495K.
- Novo Nordisk made up 0.1% of Americana Partners's portfolio in Q2 2026, its #147 holding.
- Americana Partners first reported a position in Novo Nordisk in Q4 2019 and has held it in 19 quarters since.
- Americana Partners's Novo Nordisk position peaked at $7.05M in Q2 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Americana Partners's 13F filing for Q2 2026, filed 5 Aug 2026.